- Home
- Labeler Index
- Csl Behring Ag
- 44206-455
- NDC Crossover: 44206-455 Hizentra
NDC Crossover 44206-455 Hizentra
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Human Immunoglobulin G
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 44206-455 – Hizentra, a plasma derivative. This list includes other cross-matching products that share:
- The same product name: Hizentra
- OR Generic name: Human Immunoglobulin G
- AND the same Administration Route: subcutaneous
- OR Dosage Form: liquid
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
44206-451 | Hizentra | Human Immunoglobulin G | Liquid | Subcutaneous | Csl Behring Ag | Plasma Derivative |
44206-452 | Hizentra | Human Immunoglobulin G | Liquid | Subcutaneous | Csl Behring Ag | Plasma Derivative |
44206-454 | Hizentra | Human Immunoglobulin G | Liquid | Subcutaneous | Csl Behring Ag | Plasma Derivative |
44206-456 | Hizentra | Human Immunoglobulin G | Liquid | Subcutaneous | Csl Behring Ag | Plasma Derivative |
44206-457 | Hizentra | Human Immunoglobulin G | Liquid | Subcutaneous | Csl Behring Ag | Plasma Derivative |
44206-458 | Hizentra | Human Immunoglobulin G | Liquid | Subcutaneous | Csl Behring Ag | Plasma Derivative |